Cameron John Turtle
Impact in
- Oncology top 0.05%
- CAR-T cell therapy research
- Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Oncology 159
- CAR-T cell therapy research 152
- Immunology 58
- Immune Cell Function and Interaction 22
- Biosimilars and Bioanalytical Methods 22
- Immunotherapy and Immune Responses 20
- Co-authors
- Stanley R. Riddell (56 shared papers)David G. Maloney (54 shared papers)Laïla‐Aïcha Hanafi (12 shared papers)Kevin Anthony Hay (14 shared papers)Sindhu Cherian (9 shared papers)Daniel Li (6 shared papers)Juliane Gust (5 shared papers)Xueyan Chen (8 shared papers)
- Journals
- Blood (42 papers)Transplantation and Cellular Therapy (30 papers)Blood Advances (16 papers)Journal for ImmunoTherapy of Cancer (5 papers)American Journal of Hematology (5 papers)
- Partner nations
- United StatesAustraliaSouth Africa
In The Last Decade
Cameron John Turtle
174 papers receiving 19.8k citations
Cameron John Turtle's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 15.3k
- Immunology 4.8k
- Hematology 1.5k
- Genetics 3.6k
- Genetics 968
Countries citing papers authored by Cameron John Turtle
This map shows the geographic impact of Cameron John Turtle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron John Turtle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron John Turtle more than expected).
Fields of papers citing papers by Cameron John Turtle
This network shows the impact of papers produced by Cameron John Turtle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron John Turtle. The network helps show where Cameron John Turtle may publish in the future.
Co-authors
The 25 scholars most cited alongside Cameron John Turtle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells Hit paper breakdown → | 2018 | 2781 |
| 2 | CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients Hit paper breakdown → | 2016 | 1814 |
| 3 | Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells Hit paper breakdown → | 2017 | 1144 |
| 4 | Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy Hit paper breakdown → | 2017 | 930 |
| 5 | Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells Hit paper breakdown → | 2009 | 918 |
| 6 | Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells Hit paper breakdown → | 2016 | 877 |
| 7 | Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo Hit paper breakdown → | 2015 | 739 |
| 8 | Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes Hit paper breakdown → | 2020 | 661 |
| 9 | Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy Hit paper breakdown → | 2016 | 658 |
| 10 | Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib Hit paper breakdown → | 2017 | 553 |
| 11 | HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells Hit paper breakdown → | 2017 | 513 |
| 12 | Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy Hit paper breakdown → | 2017 | 480 |
| 13 | Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma Hit paper breakdown → | 2020 | 348 |
| 14 | Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy Hit paper breakdown → | 2019 | 340 |
| 15 | 2010 | 311 | |
| 16 | 2019 | 299 | |
| 17 | 2019 | 295 | |
| 18 | 2020 | 266 | |
| 19 | Immunogenicity of CAR T cells in cancer therapy Hit paper breakdown → | 2021 | 247 |
| 20 | 2020 | 228 |
About Cameron John Turtle
Cameron John Turtle is a scholar working on Oncology, Immunology, Genetics, Pathology and Forensic Medicine and Genetics, having authored 187 papers that have together received 20.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (152 papers), Virus-based gene therapy research (25 papers), Immune Cell Function and Interaction (22 papers), Advancements in Semiconductor Devices and Circuit Design (22 papers), Biosimilars and Bioanalytical Methods (22 papers), Immunotherapy and Immune Responses (20 papers), Viral Infectious Diseases and Gene Expression in Insects (17 papers) and Silicon Carbide Semiconductor Technologies (17 papers). The work is most often cited by research in Oncology (15.3k citations), Immunology (4.8k citations), Hematology (1.5k citations), Genetics (3.6k citations) and Genetics (968 citations). Cameron John Turtle has collaborated with scholars based in United States, Australia and South Africa. Frequent co-authors include Stanley R. Riddell, David G. Maloney, Laïla‐Aïcha Hanafi, Kevin Anthony Hay, Sindhu Cherian, Daniel Li, Juliane Gust, Xueyan Chen, Michael Hudecek and Alexandre V. Vinaud Hirayama. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Blood Advances, Journal for ImmunoTherapy of Cancer and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.